IBDEI0Q7 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12877,0)
 ;;=441.9^^75^798^2
 ;;^UTILITY(U,$J,358.3,12877,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12877,1,1,0)
 ;;=1^441.9
 ;;^UTILITY(U,$J,358.3,12877,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/O RUPTURE
 ;;^UTILITY(U,$J,358.3,12877,2)
 ;;=^9277
 ;;^UTILITY(U,$J,358.3,12878,0)
 ;;=442.9^^75^798^3
 ;;^UTILITY(U,$J,358.3,12878,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12878,1,1,0)
 ;;=1^442.9
 ;;^UTILITY(U,$J,358.3,12878,1,2,0)
 ;;=2^ANEURYSM,NON-AORTIC
 ;;^UTILITY(U,$J,358.3,12878,2)
 ;;=^7390
 ;;^UTILITY(U,$J,358.3,12879,0)
 ;;=710.3^^75^798^4
 ;;^UTILITY(U,$J,358.3,12879,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12879,1,1,0)
 ;;=1^710.3
 ;;^UTILITY(U,$J,358.3,12879,1,2,0)
 ;;=2^DERMATOMYOSITIS
 ;;^UTILITY(U,$J,358.3,12879,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,12880,0)
 ;;=446.5^^75^798^5
 ;;^UTILITY(U,$J,358.3,12880,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12880,1,1,0)
 ;;=1^446.5
 ;;^UTILITY(U,$J,358.3,12880,1,2,0)
 ;;=2^GIANT CELL ARTERITIS
 ;;^UTILITY(U,$J,358.3,12880,2)
 ;;=^117658
 ;;^UTILITY(U,$J,358.3,12881,0)
 ;;=446.20^^75^798^6
 ;;^UTILITY(U,$J,358.3,12881,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12881,1,1,0)
 ;;=1^446.20
 ;;^UTILITY(U,$J,358.3,12881,1,2,0)
 ;;=2^HYPERSENSITIVITY ANGIITIS, UNS
 ;;^UTILITY(U,$J,358.3,12881,2)
 ;;=^60279
 ;;^UTILITY(U,$J,358.3,12882,0)
 ;;=446.3^^75^798^7
 ;;^UTILITY(U,$J,358.3,12882,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12882,1,1,0)
 ;;=1^446.3
 ;;^UTILITY(U,$J,358.3,12882,1,2,0)
 ;;=2^LETHAL MIDLINE GRANULOMA
 ;;^UTILITY(U,$J,358.3,12882,2)
 ;;=^52905
 ;;^UTILITY(U,$J,358.3,12883,0)
 ;;=446.1^^75^798^8
 ;;^UTILITY(U,$J,358.3,12883,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12883,1,1,0)
 ;;=1^446.1
 ;;^UTILITY(U,$J,358.3,12883,1,2,0)
 ;;=2^MUCOCUTANEOUS LYMPH SYND (MCLS)
 ;;^UTILITY(U,$J,358.3,12883,2)
 ;;=^79494
 ;;^UTILITY(U,$J,358.3,12884,0)
 ;;=443.9^^75^798^12
 ;;^UTILITY(U,$J,358.3,12884,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12884,1,1,0)
 ;;=1^443.9
 ;;^UTILITY(U,$J,358.3,12884,1,2,0)
 ;;=2^PERIPH VASCULAR DIS NOS
 ;;^UTILITY(U,$J,358.3,12884,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,12885,0)
 ;;=446.0^^75^798^13
 ;;^UTILITY(U,$J,358.3,12885,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12885,1,1,0)
 ;;=1^446.0
 ;;^UTILITY(U,$J,358.3,12885,1,2,0)
 ;;=2^POLYARTERITIS NODOSA
 ;;^UTILITY(U,$J,358.3,12885,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,12886,0)
 ;;=710.4^^75^798^14
 ;;^UTILITY(U,$J,358.3,12886,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12886,1,1,0)
 ;;=1^710.4
 ;;^UTILITY(U,$J,358.3,12886,1,2,0)
 ;;=2^POLYMYOSITIS
 ;;^UTILITY(U,$J,358.3,12886,2)
 ;;=^186822
 ;;^UTILITY(U,$J,358.3,12887,0)
 ;;=452.^^75^798^15
 ;;^UTILITY(U,$J,358.3,12887,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12887,1,1,0)
 ;;=1^452.
 ;;^UTILITY(U,$J,358.3,12887,1,2,0)
 ;;=2^PORTAL VEIN THROMBOSIS
 ;;^UTILITY(U,$J,358.3,12887,2)
 ;;=^269815
 ;;^UTILITY(U,$J,358.3,12888,0)
 ;;=714.2^^75^798^16
 ;;^UTILITY(U,$J,358.3,12888,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12888,1,1,0)
 ;;=1^714.2
 ;;^UTILITY(U,$J,358.3,12888,1,2,0)
 ;;=2^RHEUMATOID ARTHRITIS,SYSTEMIC
 ;;^UTILITY(U,$J,358.3,12888,2)
 ;;=^272111
 ;;^UTILITY(U,$J,358.3,12889,0)
 ;;=135.^^75^798^17
 ;;^UTILITY(U,$J,358.3,12889,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12889,1,1,0)
 ;;=1^135.
 ;;^UTILITY(U,$J,358.3,12889,1,2,0)
 ;;=2^SARCOIDOSIS
 ;;^UTILITY(U,$J,358.3,12889,2)
 ;;=^107916
 ;;^UTILITY(U,$J,358.3,12890,0)
 ;;=710.0^^75^798^18
 ;;^UTILITY(U,$J,358.3,12890,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12890,1,1,0)
 ;;=1^710.0
 ;;^UTILITY(U,$J,358.3,12890,1,2,0)
 ;;=2^SYST LUPUS ERYTHEMATOSIS
